← FDA Drug Approvals (Drugs@FDA)
RIVIVE
NDA · New Drug Application · Sponsor: HARM REDUCTION THERP · Approved 2023-07-28
Drug application
- FDA Application #
NDA217722- Application type
- New Drug Application
- Brand name
- RIVIVE
- Generic name
- NALOXONE HYDROCHLORIDE
- Active ingredients
- NALOXONE HYDROCHLORIDE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Over-the-counter
- Sponsor
- HARM REDUCTION THERP
- Manufacturer
- Harm Reduction Therapeutics, Inc.
- First approval
- 2023-07-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown